{"Title": "miRNA expression profiling of formalin-fixed paraffin-embedded (FFPE) hereditary breast tumors", "Year": 2015, "Source": "Genomics Data", "Volume": "3", "Issue": null, "Art.No": null, "PageStart": 75, "PageEnd": 79, "CitedBy": 10, "DOI": "10.1016/j.gdata.2014.11.008", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922899712&origin=inward", "Abstract": "\u00a9 2014 The Authors.Hereditary breast cancer constitutes only 5-10% of all breast cancer cases and is characterized by strong family history of breast and/or other associated cancer types. Only ~. 25% of hereditary breast cancer cases carry a mutation in BRCA1 or BRCA2 gene, while mutations in other rare high and moderate-risk genes and common low penetrance variants may account for additional 20% of the cases. Thus the majority of cases are still unaccounted for and designated as BRCAX tumors. MicroRNAs are small non-coding RNAs that play important roles as regulators of gene expression and are deregulated in cancer. To characterize hereditary breast tumors based on their miRNA expression profiles we performed global microarray miRNA expression profiling on a retrospective cohort of 80 FFPE breast tissues, including 66 hereditary breast tumors (13 BRCA1, 10 BRCA2 and 43 BRCAX), 10 sporadic breast carcinomas and 4 normal breast tissues, using Exiqon miRCURY LNA\u2122 microRNA Array v.11.0. Here we describe in detail the miRNA microarray expression data and tumor samples used for the study of BRCAX tumor heterogeneity (Tanic et al., 2013) and biomarkers associated with positive BRCA1/2 mutation status (Tanic et al., 2014). Additionally, we provide the R code for data preprocessing and quality control.", "AuthorKeywords": ["Hereditary breast cancer", "Microarray", "MiRNA"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84922899712", "SubjectAreas": [["Biotechnology", "BIOC", "1305"], ["Biochemistry", "BIOC", "1303"], ["Molecular Medicine", "BIOC", "1313"], ["Genetics", "BIOC", "1311"]], "AuthorData": {"54584546700": {"Name": "Tani\u0107 M.", "AuthorID": "54584546700", "AffiliationID": "60068842", "AffiliationName": "Laboratory for Molecular Genetics, Experimental Oncology Department, Institute for Oncology and Radiology of Serbia (IORS)"}, "56215775600": {"Name": "Yanowski K.", "AuthorID": "56215775600", "AffiliationID": "60008948", "AffiliationName": "Human Genetics Group, Spanish National Cancer Research Centre (CNIO)"}, "6701384111": {"Name": "Martinez-Delgado B.", "AuthorID": "6701384111", "AffiliationID": "60001602", "AffiliationName": "Molecular Genetics Unit. Human Genetics Section, Instituto de Investigaci\u00f3n en Enfermedades Raras IIER, Instituto de Salud Carlos III (ISCIII)"}, "7203010415": {"Name": "Ben\u00edtez J.", "AuthorID": "7203010415", "AffiliationID": "60085100", "AffiliationName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER)"}, "12772442200": {"Name": "Andr\u00e9s E.", "AuthorID": "12772442200", "AffiliationID": "60008948", "AffiliationName": "Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO)"}, "24279428700": {"Name": "G\u00f3mez-L\u00f3pez G.", "AuthorID": "24279428700", "AffiliationID": "60008948", "AffiliationName": "Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO)"}, "24588110800": {"Name": "Pisano D.", "AuthorID": "24588110800", "AffiliationID": "60008948", "AffiliationName": "Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO)"}, "56518077000": {"Name": "Socorro M.", "AuthorID": "56518077000", "AffiliationID": "60019290", "AffiliationName": "Pathology Department, Fundaci\u00f3n Jimenez D\u00edaz"}}}